Clinical trials
Phase 2 Lung Neoplasms trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
125 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 7 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 8 |
| 2014 | 6 |
| 2015 | 5 |
| 2016 | 7 |
| 2017 | 3 |
| 2018 | 10 |
| 2019 | 4 |
| 2020 | 14 |
| 2021 | 8 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 125 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Center, Korea | 6 |
| Sun Yat-sen University | 5 |
| Sichuan Cancer Hospital and Research Institute | 4 |
| Yonsei University | 4 |
| GERCOR - Multidisciplinary Oncology Cooperative Group | 3 |
| Zhejiang Cancer Hospital | 3 |
| Centre Henri Becquerel | 2 |
| Chinese Academy of Medical Sciences | 2 |
| First Hospital of Shijiazhuang City | 2 |
| Fudan University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 125 |
| Carcinoma, Non-Small-Cell Lung | 58 |
| Adenocarcinoma of Lung | 7 |
| Small Cell Lung Carcinoma | 6 |
| Adenocarcinoma, Bronchiolo-Alveolar | 4 |
| Brain Neoplasms | 4 |
| Breast Neoplasms | 4 |
| Neoplasms | 4 |
| Carcinoma | 3 |
| Colorectal Neoplasms | 2 |
Trials
Showing 1 to 25 of 125. Each trial links to its page on Pharma Observatory.
25 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.